Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Semiconductor diode laser device adjuvanting intradermal vaccine.

Yoshifumi Kimizuka1, John J Callahan2, Zilong Huang3

  • 1Vaccine and Immunotherapy Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, 149 13th Street, Charlestown, MA 02129, United States.

Vaccine
|April 3, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visualization of the microstructure and distribution of follicles in deep human ovaries using speckle-modulated optical coherence microscopy.

PloS one·2026
Same author

VEBrant: a multicenter, phase II study of MET inhibitor vebreltinib combined with PD-1-based immunotherapy in advanced clear cell sarcoma.

Future oncology (London, England)·2026
Same author

Long-term real-world effectiveness and safety of edoxaban in chronic thromboembolic pulmonary hypertension: a nationwide registry study.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Real-World Outcomes of Ultrasound-Guided Carpal Tunnel Release in 1,082 Hands: 6-Month Results From the MISSION Registry.

Journal of hand surgery global online·2026
Same author

A modified Delphi consensus on tenosynovial giant cell tumour and giant cell tumour of bone : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).

The bone & joint journal·2026
Same author

Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysis.

Bone & joint open·2026

Low-power laser light can boost immune responses to vaccines. A new, affordable handheld near-infrared laser device replicates this effect, paving the way for widespread clinical use in mass vaccination programs.

Area of Science:

  • Immunology
  • Biomedical Engineering
  • Laser Technology

Background:

  • Low-power laser light exposure enhances immune responses to intradermal vaccination.
  • Current laser adjuvant systems use expensive diode-pumped solid-state lasers (DPSSLs) requiring specialized maintenance.
  • A need exists for cost-effective, user-friendly laser devices for clinical vaccine adjuvant applications.

Purpose of the Study:

  • To develop and evaluate a novel, inexpensive handheld near-infrared (NIR) laser device as a vaccine adjuvant.
  • To determine if this new device can replicate the immune-enhancing effects of traditional DPSSL systems.
  • To explore the feasibility of using NIR laser adjuvants in mass vaccination settings.

Main Methods:

  • Development of a handheld NIR laser device utilizing semiconductor diodes (1061, 1258, or 1301nm).
Keywords:
AdjuvantHandheldLaserNear-infraredSemiconductor laser diodeVaccine

Related Experiment Videos

  • Evaluation of the device's adjuvant effect in a mouse model of influenza vaccination.
  • Comparison of the novel device's efficacy against established DPSSL systems.

    • Main Results:

    • The developed handheld NIR laser device successfully replicated the adjuvant effect of a DPSSL system in a mouse influenza vaccination model.
    • The study identified a broader range of NIR laser wavelengths capable of enhancing vaccine immune responses.
    • The low-cost (<$4000) device demonstrated significant potential for clinical translation.

    Conclusions:

    • A novel, low-cost handheld NIR laser device effectively enhances vaccine immune responses, mimicking established DPSSL systems.
    • This technology is suitable for mass vaccination programs and broad testing with various vaccines.
    • The findings lay the groundwork for developing clinical-ready laser adjuvant devices.